Board of Cadila Healthcare approves transfer of animal healthcare business to subsidiary

At meeting held on 11 March 2020

The Board of Cadila Healthcare at its meeting held on 11 March 2020 has approved the transfer of Animal Healthcare Business (AHB) of the Company, on a going concern basis, to its wholly owned subsidiary Zydus Animal Health and Investments (ZAHL) through execution of a Definitive Agreement.

AHB consists of the business of development, manufacturing, marketing and selling of Animal Healthcare products in India and other countries.

The transfer of AHB to ZAHL is subject to satisfaction of certain conditions precedent as provided in the Definitive Agreement.

Powered by Capital Market - Live News